| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is demonstrating significant advancements in product development, particularly in obesity drug development where the company is focusing on innovative treatments with proven efficacy. Successful clinical trials, including those for their new obesity pill and retatrutide, underscore their strong commitment to enhancing patient outcomes. The ongoing progress in their pharmaceutical offerings reflects a dedicated effort toward addressing pressing health issues such as obesity. This robust pipeline of effective drugs positions Eli Lilly favorably in the competitive pharmaceutical landscape. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.6 is bearish. The market sentiment at 0.8 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at -0.1 on 2025-12-11. The forces of Stock Price Trend (-0.6), and Market Risk Appetite (-0.1) will drive down the price. The forces of Price Level Sentiment (0), Sector Price Trend (0.1), Option Sentiment (0.8), Valuation Sentiment (1.1), and Sentiment towards Fundamentals (3.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | 0%(0%) | 1009.14 | 29 | 1.63% | -0.92% | -0.6 | 0.05% | 1.3% | 0.8 | Wait | 50% | 3.6 | 7 |
| 2025-12-10 | 0%(0%) | 992.94 | 16 | 1.15% | -1.12% | -0.5 | 0.02% | 0.6% | 0.9 | Wait | 50% | 3.1 | 7 |
| 2025-12-09 | 0%(0%) | 981.67 | 8 | -1.59% | -0.82% | -0.7 | -0.15% | 0.9% | 1 | Wait | 50% | 2.7 | 6 |
| 2025-12-08 | 0%(0%) | 997.57 | 22 | -1.26% | -0.59% | -0.4 | -0.12% | 0.9% | 0.9 | Wait | 50% | 2.4 | 7 |
| 2025-12-07 | 0%(0.1%) | -0.5 | -0.11% | 0.5 | 2.8 | -1 | |||||||
| 2025-12-06 | 0%(0.1%) | -0.5 | -0.11% | 0.6 | 2.9 | -1 | |||||||
| 2025-12-05 | 0%(0.3%) | 1010.29 | 36 | -0.35% | -0.31% | -0.5 | -0.11% | 1.1% | 0.8 | Short | 65% | 3 | -1 |
| 2025-12-04 | 0%(0.3%) | 1013.84 | 42 | -1.87% | -0.34% | -0.8 | -0.2% | 1.6% | 0.8 | Short | 65% | 3.1 | -1 |
| 2025-12-03 | 0%(0.3%) | 1033.17 | 54 | -1.16% | 0.03% | -0.1 | -0.03% | 1% | 0.9 | Short | 60% | 3.1 | -1 |
| 2025-12-02 | 0%(0.3%) | 1045.33 | 61 | -1.21% | 0.21% | 0.4 | 0.1% | 0.6% | 1.1 | Long | 65% | 3.2 | 7 |
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-12-11 17:02:29 Prison Fellowship's grant from Lilly Endowment signifies an investment in community programs linked to the Lilly brand. |
| 2025-12-11 17:02:29 Positive results from clinical trials are boosting investor confidence and the company's earnings outlook. |
| 2025-12-11 17:02:29 Eli Lilly is facing competition from other firms introducing new weight-loss medications. |
| 2025-12-11 17:02:29 Positive news around obesity drug trials has influenced Eli Lilly's stock performance positively. |
| 2025-12-11 17:02:29 Eli Lilly is advancing its product line with new obesity drugs showing promising clinical results. |
| 2025-12-11 11:48:49 The introduction of retatrutide signifies a strategic move that positions Eli Lilly favorably in the competitive landscape of obesity treatments, aligning with current health trends. |
| 2025-12-11 11:48:49 Eli Lilly's focus on developing retatrutide as a significant addition to their obesity treatment offerings highlights the company's ongoing commitment to addressing obesity through innovative solutions. |
| 2025-12-11 09:35:35 The reported efficacy of Lilly's drug in achieving substantial weight loss is a key highlight, showcasing significant patient benefits. |
| 2025-12-11 09:35:35 The growing competition within the obesity drug market is emphasized by Lilly's product outperforming competitors, specifically Zepbound. |
| 2025-12-11 09:35:35 Eli Lilly's advancements in obesity drug development focus on boosting weight loss results, illustrating a significant progress in this area. |